mk-0524 and Kidney-Failure--Chronic

mk-0524 has been researched along with Kidney-Failure--Chronic* in 1 studies

Other Studies

1 other study(ies) available for mk-0524 and Kidney-Failure--Chronic

Article	Year
Sustained hypophosphatemic effect of once-daily niacin/laropiprant in dyslipidemic CKD stage 3 patients. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2011, Volume: 57, Issue:6 Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyslipidemias; Humans; Hypolipidemic Agents; Hypophosphatemia; Indoles; Kidney Failure, Chronic; Lipids; Niacin; Treatment Outcome	2011

Article

Year

Sustained hypophosphatemic effect of once-daily niacin/laropiprant in dyslipidemic CKD stage 3 patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2011, Volume: 57, Issue:6

Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyslipidemias; Humans; Hypolipidemic Agents; Hypophosphatemia; Indoles; Kidney Failure, Chronic; Lipids; Niacin; Treatment Outcome

2011